These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4425853)

  • 21. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study.
    Lowe GD; Fowkes FG; Dawes J; Donnan PT; Lennie SE; Housley E
    Circulation; 1993 Jun; 87(6):1915-20. PubMed ID: 8504504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina.
    Nicolaides AN; Horbourne T; Bowers R; Kidner PH; Besterman EM
    Lancet; 1977 Nov; 2(8045):943-5. PubMed ID: 72287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: significance of raised plasma fibrinogen in 95 patients with intermittent claudication.
    Dormandy JA; Dormandy TL; Arrowsmith D
    Br J Surg; 1973 Nov; 60(11):914. PubMed ID: 4752787
    [No Abstract]   [Full Text] [Related]  

  • 24. Fish oil supplementation in patients with stable claudication.
    Gans RO; Bilo HJ; Weersink EG; Rauwerda JA; Fonk T; Popp-Snijders C; Donker AJ
    Am J Surg; 1990 Nov; 160(5):490-5. PubMed ID: 2240382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clofibrate and niacin in coronary heart disease.
    JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.
    Wolfe BM; Kane JP; Havel RJ; Brewster HP
    J Clin Invest; 1973 Sep; 52(9):2146-59. PubMed ID: 4353773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood viscosity and hematocrit indices in arteriosclerosis].
    Kazakov IuM
    Vrach Delo; 1981 Feb; (2):27-8. PubMed ID: 7222603
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
    Poredos P; Zizek B
    Angiology; 1996 Mar; 47(3):253-9. PubMed ID: 8638868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
    Mika P; Wilk B; Mika A; Marchewka A; Nizankowski R
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):754-60. PubMed ID: 21450630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease.
    Gaddi A; Galetti C; Illuminati B; Nascetti S
    J Int Med Res; 1996; 24(5):389-406. PubMed ID: 8895043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy in intermittent claudication: an objective assessment of the effects of three drugs on patients with intermittent claudication.
    Mashiah A; Patel P; Schraibman IG; Charlesworth D
    Br J Surg; 1978 May; 65(5):342-5. PubMed ID: 647201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of clofibrate on myocardial triglyceride accumulation in female obese Zucker rats].
    Yang BX; Li Y; Liao R; Tian Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):962-4. PubMed ID: 19253836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effects of intravenous iloprost in patients with intermittent claudication.
    Müller-Bühl U; Diehm C; Krais T; Zimmermann R; Mörl H; Eckstein HH
    Eur J Clin Pharmacol; 1987; 33(2):127-31. PubMed ID: 2446877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentoxifylline for intermittent claudication. A critical review.
    Ernst E
    Angiology; 1994 May; 45(5):339-45. PubMed ID: 8172380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of fatty meals on blood viscosity.
    Begg TB; Hearns JB
    Clin Sci; 1967 Jun; 32(3):551-7. PubMed ID: 6028132
    [No Abstract]   [Full Text] [Related]  

  • 39. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
    Paul HS; Adibi SA
    J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An assessment of red cell deformability using a simple filtration method.
    Drummond MM; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    J Clin Pathol; 1980 Apr; 33(4):373-6. PubMed ID: 6772688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.